Advanzeon Solutions, Inc. - Quarter Report: 2007 June (Form 10-Q)

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

þ		Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2007.

o		Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from _____________  to _____________. Commission File Number 1-9927

COMPREHENSIVE CARE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		95-2594724
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

3405 W. Dr. Martin Luther King Jr. Blvd, Suite 101, Tampa, FL 33607

(Address of principal executive offices and zip code)

(813) 288-4808

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes  þ      No   o

     Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

      

Large Accelerated Filer  o		Accelerated Filer  o		Non-Accelerated Filer  þ

     Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  o     No  þ

     Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock, as of the latest practicable date:

Class		Outstanding at August 6, 2007
Common Stock, par value $.01 per share		7,702,781

 

 

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Index

						PAGE
PART I — FINANCIAL INFORMATION
			Item 1— Consolidated Financial Statements
				Consolidated Balance Sheets as of June 30, 2007 and December 31, 2006			3
				Consolidated Statements of Operations for the three and six months ended June 30, 2007 and 2006			4
				Consolidated Statements of Cash Flows for the six months ended June 30, 2007 and 2006			5
				Notes to Consolidated Financial Statements			6-13
			Item 2— Management’s Discussion and Analysis of Financial Condition and Results of Operations				13-21
			Item 3— Quantitative and Qualitative Disclosures About Market Risk				21
			Item 4— Controls and Procedures				21
PART II — OTHER INFORMATION
			Item 1— Legal Proceedings				21-22
			Item 1A — Risk Factors				22
			Item 2— Unregistered Sales of Equity Securities and Use of Proceeds				22
			Item 3— Defaults Upon Senior Securities				22
			Item 4— Submission of Matters to a Vote of Security Holders				22
			Item 5— Other Information				22
			Item 6— Exhibits				22
			Signatures				23
			Certifications
EX-31.1 SECTION 302 CERTIFICATION OF THE CEO
EX-31.2 SECTION 302 CERTIFICATION OF THE CFO
EX-32.1 SECTION 906 CERTIFICATION OF THE CEO
EX-32.2 SECTION 906 CERTIFICATION OF THE CFO

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

PART I — FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Consolidated Balance Sheets
(Amounts in thousands)

		June 30,				December 31,
		2007				2006
		(unaudited)
ASSETS
Current assets:
Cash and cash equivalents		$	7,216				5,543
Accounts receivable, less allowance for doubtful accounts of $1 and $6, respectively			101				163
Other current assets			496				793
Total current assets			7,813				6,499
Property and equipment, net			373				377
Note receivable			31				44
Goodwill, net			991				991
Other assets			150				203
Total assets			9,358				8,114
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued liabilities			1,783				1,201
Accrued claims payable			5,183				2,746
Accrued reinsurance claims payable			2,526				2,516
Income taxes payable			46				50
Total current liabilities			9,538				6,513
Long-term liabilities:
Long-term debt			2,244				2,244
Other liabilities			144				160
Total long-term liabilities			2,388				2,404
Total liabilities			11,926				8,917
Stockholders’ deficit:
Preferred stock, $50.00 par value; authorized 18,740 shares; 14,400 issued			720				720
Common stock, $0.01 par value; authorized 30,000,000 shares; issued and outstanding 7,702,783 and 7,655,283, respectively			77				77
Additional paid-in capital			57,587				57,503
Accumulated deficit			(60,952	)			(59,103	)
Total stockholders’ deficit			(2,568	)			(803	)
Total liabilities and stockholders’ deficit		$	9,358				8,114

See accompanying notes to consolidated financial statements.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Consolidated Statements of Operations
(Unaudited)
(Amounts in thousands, except per share amounts)

		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2007				2006				2007				2006
Operating revenues		$	9,159				4,924				17,860				10,033
Costs and expenses:
Healthcare operating expenses			9,348				4,161				17,611				8,308
General and administrative expenses			931				790				2,012				1,585
Provision for (recovery of) doubtful accounts			2				4				(8	)			(52	)
Depreciation and amortization			38				22				76				43
			10,319				4,977				19,691				9,884
Operating (loss) income before items shown below			(1,160	)			(53	)			(1,831	)			149
Other income (expense):
Gain from sale of available-for-sale securities			29				—				29				—
Loss from software development			—				(21	)			—				(123	)
Loss on impairment — investment in marketable securities			—				(17	)			—				(17	)
Interest income			48				29				72				54
Interest expense			(48	)			(48	)			(95	)			(93	)
Other non-operating income			—				10				—				10
Loss before income taxes			(1,131	)			(100	)			(1,825	)			(20	)
Income tax expense			14				35				24				49
Net loss attributable to common stockholders			(1,145	)			(135	)			(1,849	)			(69	)
Net loss per common share — basic and diluted		$	(0.15	)			(0.02	)			(0.24	)			(0.01	)
Weighted average common shares outstanding:
Basic			7,703				5,892				7,692				5,875
Diluted			7,703				5,892				7,692				5,875

See accompanying notes to consolidated financial statements.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows
(Unaudited)
(Amounts in thousands)

		Six Months Ended
		June 30,
		2007				2006
Cash flows from operating activities:
Net loss		$	(1,849	)			(69	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization			76				43
Asset writedown — eye care memberships			62				63
Asset write-off			3				—
Compensation expense — stock options issued			40				8
Loss from software development			—				123
Gain from sale of available-for-sale securities			(29	)			—
Loss on impairment — investment in marketable securities			—				17
Non cash expense — stock issued			25				27
Amortization of deferred revenue			—				(4	)
Changes in assets and liabilities:
Accounts receivable, net			62				(442	)
Accounts receivable — managed care reinsurance contract			—				454
Other current assets and other non-current assets			288				250
Accounts payable and accrued liabilities			604				141
Accrued claims payable			2,437				(1,162	)
Accrued reinsurance claims payable			10				(607	)
Income taxes payable			(4	)			16
Other liabilities			(19	)			—
Net cash provided by (used in) continuing operations			1,706				(1,142	)
Net cash used in discontinued operations			(20	)			—
Net cash provided by (used in) continuing and discontinued operations			1,686				(1,142	)
Cash flows from investing activities:
Net proceeds from sale of available-for-sale securities			30				—
Payment received on notes receivable			12				—
Additions to property and equipment, net			(46	)			(28	)
Net cash used in investing activities			(4	)			(28	)
Cash flows from financing activities:
Proceeds from the issuance of common stock			19				21
Repayment of debt			(28	)			(32	)
Net cash used in financing activities			(9	)			(11	)
Net increase (decrease) in cash and cash equivalents			1,673				(1,181	)
Cash and cash equivalents at beginning of period			5,543				6,288
Cash and cash equivalents at end of period		$	7,216				5,107
Supplemental disclosures of cash flow information:
Cash paid during the six-month period for:
Interest		$	95				93
Income taxes		$	30				32
Non-cash operating, financing and investing activities:
Property acquired under capital leases		$	34				136

See accompanying notes to consolidated financial statements.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Note 1 — Description of the Company’s Business and Basis of Presentation

     Comprehensive Care Corporation (the “Company” or “CompCare”) is a Delaware Corporation organized in 1969. Unless the context otherwise requires, all references to the “Company” include Comprehensive Behavioral Care, Inc. (“CBC”) and subsidiary corporations. The Company, primarily through its wholly owned subsidiary, CBC, provides managed care services in the behavioral health and psychiatric fields, which is its only operating segment. The Company manages the delivery of a continuum of psychiatric and substance abuse services to commercial, Medicare, Medicaid and Children’s Health Insurance Program (“CHIP”) members on behalf of employers, health plans, government organizations, third-party claims administrators, and commercial and other group purchasers of behavioral healthcare services. The Company also provides prior and concurrent authorization for physician-prescribed psychotropic medications for a major Medicaid health maintenance organization (“HMO”) in Indiana and Michigan. The managed care operations include administrative service agreements, fee-for-service agreements, and capitation contracts. The customer base for its services includes both private and governmental entities. The Company’s services are provided primarily by unrelated vendors on a subcontract basis.

     The Company’s Board of Directors approved on May 21, 2007 a change in the Company’s fiscal year end from May 31 to December 31, effective December 31, 2006. The purpose of the change is to align the Company’s fiscal year end with that of Hythiam, Inc. to obtain reporting efficiencies and cost reductions. Hythiam purchased a majority, controlling interest in the Company through its purchase of Woodcliff Healthcare Investment Partners LLC (Woodcliff) in January 2007. In addition, a calendar year end will coincide with that of a new client that is estimated to provide approximately 41% of our annual revenues during the 2007 calendar year. The seven months ended December 31, 2006 was the Company’s transition period. The Company’s new fiscal year began January 1, 2007 and will end December 31, 2007.

Note 2 — Summary of Significant Accounting Policies

     The consolidated balance sheet as of June 30, 2007, the consolidated statements of operations for the three and six months ended June 30, 2007 and 2006, and the consolidated statements of cash flows for the six months ended June 30, 2007 and 2006 are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments necessary for a fair presentation of such consolidated financial statements have been included. Such adjustments consisted only of normal recurring items. The results of operations for the six months ended June 30, 2007 are not necessarily indicative of the results to be expected during the balance of the fiscal year.

     The consolidated financial statements do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. The consolidated balance sheet as of December 31, 2006 has been derived from the audited, consolidated financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statement presentation. Notes to consolidated financial statements included in Form 10-K for the transition period ended December 31, 2006 are on file with the Securities and Exchange Commission (“SEC”) and provide additional disclosures and a further description of accounting policies.

Revenue Recognition

     The Company’s managed care activities are performed under the terms of agreements with health maintenance organizations, preferred provider organizations, and other health plans or payers to provide contracted behavioral healthcare services to subscribing participants. Revenue under a substantial portion of these agreements is earned monthly based on the number of qualified participants regardless of services actually provided (generally referred to as capitation arrangements). The information regarding qualified participants is supplied by the Company’s clients and the Company reviews member eligibility records and other reported information to verify its accuracy to determine the amount of revenue to be recognized. Such agreements accounted for 96.9%, or $17.3 million, of revenue for the six months ended June 30, 2007 and 96.8%, or $9.7 million, of revenue for the six months ended June 30, 2006. The remaining balance of the Company’s revenues is earned on a fee-for-service basis and is recognized as services are rendered.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Healthcare Expense Recognition

     Healthcare operating expense is recognized in the period in which an eligible member actually receives services and includes an estimate of the cost of behavioral health services that have been incurred but not yet reported. See “Accrued Claims Payable” for a discussion of claims incurred but not yet reported. The Company contracts with various healthcare providers including hospitals, physician groups and other licensed behavioral healthcare professionals either on a discounted fee-for-service or a per-case basis. The Company determines that a member has received services when the Company receives a claim within the contracted timeframe with all required billing elements correctly completed by the service provider. The Company then determines that the member is eligible to receive such services, the service provided is medically necessary and is covered by the benefit plan’s certificate of coverage, and the service is authorized by one of our employees. If all of these requirements are met, the claim is entered into the Company’s claims system for payment.

Accrued Claims Payable

     The accrued claims payable liability represents the estimated ultimate net amounts owed for all behavioral healthcare services provided through the respective balance sheet dates, including estimated amounts for claims incurred but not yet reported (“IBNR”) to the Company. The unpaid claims liability is estimated using an actuarial paid completion factor methodology and other statistical analyses and is continually reviewed and adjusted, if necessary, to reflect any change in the estimated liability. These estimates are subject to the effects of trends in utilization and other factors. However, actual claims incurred could differ from the estimated claims payable amount reported. Although considerable variability is inherent in such estimates, management believes that the unpaid claims liability is adequate.

Premium Deficiencies

     The Company accrues losses under its capitated contracts when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company performs this loss accrual analysis on a specific contract basis taking into consideration such factors as future contractual revenue, projected future healthcare and maintenance costs, and each contract’s specific terms related to future revenue increases as compared to expected increases in healthcare costs. The projected future healthcare and maintenance costs are estimated based on historical trends and the Company’s estimate of future cost increases.

     At any time prior to the end of a contract or contract renewal, if a capitated contract is not meeting its financial goals, the Company generally has the ability to cancel the contract with 60 to 90 days’ written notice. Prior to cancellation, the Company will usually submit a request for a rate increase accompanied by supporting utilization data. Although the Company’s clients have historically been generally receptive to such requests, no assurance can be given that such requests will be fulfilled in the future in the Company’s favor. If a rate increase is not granted, the Company has the ability, in most cases, to terminate the contract and limit its risk to a short-term period.

     On a quarterly basis, the Company performs a review of its portfolio of contracts for the purpose of identifying loss contracts (as defined in the American Institute of Certified Public Accountants Audit and Accounting Guide — Health Care Organizations) and developing a contract loss reserve, if applicable, for succeeding periods. During the three months ended June 30, 2007, the Company’s review did not identify any contracts where it was probable that a loss had been incurred and for which a loss could reasonably be estimated.

Income Taxes

     Under the asset and liability method of Statement of Financial Accounting Standards (SFAS) No. 109, “Accounting for Income Taxes,” deferred tax assets and liabilities are recognized for the future tax consequences attributable to net operating loss carryforwards and to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under SFAS No. 109, the effect of a change in tax rates on deferred tax assets or liabilities is recognized in the consolidated statements of operations in the period that included the enactment. A valuation allowance is established for deferred tax assets unless their realization is considered more likely than not.

     In June 2006, the FASB issued Interpretation No. 48, “Accounting for Uncertainty in Income Taxes,” (“FIN 48”) which clarifies the accounting for uncertainty in income taxes. FIN 48 requires that companies recognize in the consolidated financial statements the impact of a tax position, if that position is more likely than not of being

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

sustained on audit, based on the technical merits of the position. FIN 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods and disclosure. The provisions of FIN 48 are effective for years beginning after December 15, 2006. The Company adopted FIN 48 on January 1, 2007 with no impact on its consolidated financial statements.

     On January 12, 2007, the sale of Woodcliff’s majority interest in the Company to Hythiam constituted a “change of ownership” under IRS Section 382 rules, which impose limitations on the ability to deduct prior period net operating losses on current federal tax returns. In the event that the Company has two or more ownership changes, Section 1.382-5(d) also describes a potential impact on the limitation for any losses attributable to the period preceding the earlier ownership change. The Company has determined that the latest change of ownership does not change the limitation of approximately $400,000 per year for net operating losses incurred prior to June 14, 2005, the date of the first change in control. Furthermore, the Company’s ability to use net operating losses incurred between June 15, 2005 and January 11, 2007 is limited to approximately $490,000 per year. Net operating losses for periods prior to June 15, 2005 and for the subsequent period of June 15, 2005 to January 11, 2007 may be deducted simultaneously subject to the applicable limitations. Any unused portion of such limitations can be carried forward to the following year. The Company may be subject to further limitation in the event that the Company issues or agrees to issue substantial amounts of additional equity.

Stock Options

     The Company issues stock options to its employees and non-employee directors (“optionees”) allowing optionees to purchase the Company’s common stock pursuant to shareholder-approved stock option plans. The Company currently has two active incentive plans, the 1995 Incentive Plan and the 2002 Incentive Plan (collectively, the “Plans”), that provide for the granting of stock options, stock appreciation rights, limited stock appreciation rights, and restricted stock grants to eligible employees and consultants to the Company. Grants issued under the Plans may qualify as incentive stock options (“ISOs”) under Section 422A of the Internal Revenue Code. Options for ISOs may be granted for terms of up to ten years and are generally exercisable in cumulative increments of 50% each six months. Options for non-statutory stock options (“NSOs”) may be granted for terms of up to 13 years. The exercise price for ISOs must equal or exceed the fair market value of the shares on the date of grant, and 65% in the case of other options. The Plans also provide for the full vesting of all outstanding options under certain change of control events. The maximum number of shares authorized for issuance is 1,000,000 under the 2002 Incentive Plan and 1,000,000 under the 1995 Incentive Plan. As of June 30, 2007, under the 2002 Incentive Plan, there were 520,000 options available for grant and there were 440,000 options outstanding and exercisable. Additionally, as of June 30, 2007, under the 1995 Incentive Plan, there were 485,375 options outstanding and exercisable. Effective August 31, 2005, the 1995 Incentive Plan terminated such that there are no further options available for grant under this plan.

     The Company also has a non-qualified stock option plan for its outside directors (the “Directors’ Plan”). Each non-qualified stock option is exercisable at a price equal to the average of the closing bid and asked prices of the common stock in the over-the-counter market for the last preceding day there was a sale of the stock prior to the grant date. Grants of options vest in accordance with vesting schedules established by the Company’s Compensation and Stock Option Committee. Upon joining the Board, directors receive an initial grant of 25,000 options. Annually, directors are granted 15,000 options on the date of the Company’s annual meeting. As of June 30, 2007, under the Directors’ Plan, there were 818,336 shares available for option grants and there were 83,332 options outstanding and exercisable.

     Prior to June 1, 2006, as permitted by Statement of Financial Accounting Standards (“SFAS”) No. 148, “Accounting for Stock-Based Compensation-Transitional Disclosure,” the Company elected to follow Accounting Principles Board Opinion No. 25, (“APB 25”) “Accounting for Stock Issued to Employees” and related interpretations in accounting for its employee stock options. Under APB 25, in the event that the exercise price of the Company’s employee stock options is less than the market price of the underlying stock on the date of grant, compensation expense is recognized. Because all options granted under the Company’s employee stock option plans had an exercise price equal to the market value of the underlying common stock on the date of grant, no stock-based employee compensation cost was reflected in net (loss) income.

     Effective June 1, 2006, the Company adopted SFAS No. 123(R), “Share-Based Payment,” using the modified prospective method, which requires companies to measure compensation cost for stock options issued to employees or non-employee directors at fair value on the grant date and recognize compensation cost over the service period for those options expected to vest. The Company uses a Black-Scholes valuation model to determine the fair value of options on the grant date, which is the same model previously utilized for footnote disclosures required under SFAS No. 148, “Accounting for Stock-Based Compensation-Transitional Disclosure.” The following table illustrates the

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

effect on net (loss) income and (loss) income per share if the Company had applied the fair value recognition provisions of SFAS No. 123R to stock-based employee compensation.

		Three
		Months				Six Months
(in thousands except for per share information)		Ended				Ended
		6/30/06				6/30/06
Net loss as reported		$	(135	)			(69	)
Add:
Total stock-based employee compensation expense included in related net loss, net of related tax effects			8				8
Deduct:
Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects			(63	)			(138	)
Pro forma net loss		$	(190	)			(199	)
Loss per common share:
Basic — as reported			(0.02	)			(0.01	)
Diluted — as reported			(0.02	)			(0.01	)
Basic — pro forma			(0.03	)			(0.03	)
Diluted — pro forma			(0.03	)			(0.03	)

     A summary of activity throughout the quarter ended June 30, 2007 is as follows:

										Weighted-Average
						Weighted-				Remaining				Aggregate
						Average				Contractual				Intrinsic
Options		Shares				Exercise Price				Term				Value
Outstanding at April 1, 2007			1,048,707			$	1.35
Granted			—				—
Exercised			—				—
Forfeited or expired			(40,000	)		$	1.85
Outstanding at June 30, 2007			1,008,707			$	1.33			4.95 years					—
Exercisable at June 30, 2007			1,008,707			$	1.33			4.95 years					—

     The following table summarizes information about options granted, exercised, and vested for the three months and six months ended June 30, 2007 and 2006.

		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2007				2006				2007				2006
Options granted			—				—				—				125,000
Weighted-average grant-date fair value ($)			—				—				—				1.43
Options exercised			—				26,333				37,500				26,333
Total intrinsic value of exercised options ($)			—				35,922				13,160				35,922
Fair value of vested options ($)			3,423				153,506				78,346				155,217

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

     Stock options were granted to Board of Director members and certain employees during the six months ended June 30, 2006. No stock options were exercised during the three months ended June 30, 2007. A total of 37,500 options were exercised during the six months ended June 30, 2007. Total intrinsic value of exercised options during the six months ended June 30, 2007 was $13,160. Cash received from option exercise under all plans for the six months ended June 30, 2007 and 2006 was $19,000 and $21,000, respectively. For the three months and six months ended June 30, 2006, 26,333 options with a total intrinsic value of $35,922 were exercised. During the three months ended June 30, 2007, 40,000 stock options granted to one board of director member were cancelled due to the recipient’s resignation from the Board.

     At June 30, 2007, all stock options were vested. The Company recognized approximately $7,100 of tax benefits attributable to stock-based compensation expense recorded during the six months ended June 30, 2007. This benefit was fully offset by a valuation allowance of the same amount due to the likelihood of future realization.

     The following table lists the assumptions utilized in applying the Black-Scholes valuation model. The Company uses historical data to estimate the expected term of the option. Expected volatility is based on the historical volatility of the Company’s traded stock. The Company did not declare dividends in the past nor does it expect to do so in the near future, and as such it assumes no expected dividend. The risk-free rate is based on the U.S. Treasury yield curve with the same expected term as that of the option at the time of grant.

		Three Months Ended June 30,								Six Months Ended June 30,
		2007				2006				2007				2006
Volatility factor of the expected market price of the Company’s common stock			—				—				—				107.0	%
Expected life (in years) of the options			—				—				—				5
Risk-free interest rate			—				—				—				4.61	%
Dividend yield			—				—				—				0	%

     The Company did not grant any stock options during the three months ended June 30, 2007 or 2006, nor the six months ended June 30, 2007.

Per Share Data

     In calculating basic loss per share, net loss is divided by the weighted average number of common shares outstanding for the period. For the periods presented, diluted loss per share is equivalent to basic loss per share. The following table sets forth the computation of basic and diluted loss per share in accordance with SFAS No. 128, “Earnings Per Share” (amounts in thousands, except per share data):

		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2007				2006				2007				2006
Numerator:
Net loss		$	(1,145	)			(135	)			(1,849	)			(69	)
Denominator:
Weighted average shares — basic			7,703				5,892				7,692				5,875
Effect of dilutive securities:
Employee stock options			—				—				—				—
Warrants			—				—				—				—
Weighted average shares — diluted			7,703				5,892				7,692				5,875
Loss per share — basic and diluted		$	(0.15	)			(0.02	)			(0.24	)			(0.01	)

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

     Authorized shares of common stock reserved for possible issuance for convertible debentures, convertible preferred stock, stock options, and warrants are as follows at June 30, 2007:

Convertible debentures(a)			15,051
Convertible preferred stock(b)			4,235,328
Outstanding stock options(c)			1,008,707
Outstanding warrants(d)			406,000
Possible future issuance under stock option plans			1,338,336
Total			7,003,422

(a) The debentures are convertible into 15,051 shares of common stock at a conversion price of $149.09 per share.

(b) The Series A Convertible Preferred Stock (“Series A Preferred Stock”) is convertible into 4,235,328 shares of common stock at a conversion rate of 294.12 common shares for each preferred share.

(c) Options to purchase common stock of the Company have been issued to employees and non-employee Board of Director members with exercise prices ranging from $.25 to $4.00.

(d) Warrants to purchase common stock of the Company have been issued to certain individuals or vendors in exchange for consulting services. All such warrants were issued in lieu of cash compensation and have five-year terms with exercise prices ranging from $1.09 to $5.00.

Note 3 — Liquidity

     During the six months ended June 30, 2007, net cash provided by continuing and discontinued operations amounted to $1.7 million, primarily due to timing differences of monies received from the Company’s new major contract in Indiana that started January 1, 2007 and claims received for payment from providers related to this contract (see Note 5 — “Major Customers/Contracts”). Cash flows attributed to investing activities consist primarily of $46,000 in outflows for additions to property and equipment offset by $30,000 in cash provided by proceeds from available-for-sale securities. As of June 30, 2007, the Company had cash reserves of $7.2 million, a working capital deficit of $1.7 million and a stockholders’ deficit of $2.6 million. Management believes the Company has sufficient cash reserves to sustain current operations and to meet the Company’s current obligations.

Note 4 — Sources Of Revenue

     The Company’s revenue can be segregated into the following significant categories:

		Three Months				Three Months				Six Months				Six Months
		Ended				Ended				Ended				Ended
		6/30/07				6/30/06				6/30/07				6/30/06
Capitated contracts		$	8,848			$	4,762			$	17,315			$	9,714
Non-capitated contracts			311				162				545				319
Total		$	9,159			$	4,924			$	17,860			$	10,033

     Capitated revenues include contracts under which the Company assumes the financial risk for the costs of member behavioral healthcare services in exchange for a fixed, per member per month fee. For non-capitated contracts, the Company may manage behavioral healthcare programs or perform various managed care functions, such as clinical care management, provider network development, and claims processing without assuming financial risk for member behavioral healthcare costs.

Note 5 — Major Customers/Contracts

(1) In January 2006, the Company received written notice from a Texas HMO client that the HMO had determined to establish its own behavioral health unit and therefore was canceling services provided by the Company effective May 31, 2006. The Company had served commercial, Medicaid, and Children’s Health Insurance Program (“CHIP”) members under this contract, which accounted for approximately 22.1%, or $2.2 million of the Company’s operating revenues during the six months ended June 30, 2006. The HMO had been a client of the Company since November 1998.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

(2) In January 2007 the Company began providing behavioral health services to approximately 250,000 Indiana Medicaid recipients pursuant to a contract with an Indiana HMO. The contract accounted for approximately $7.5 million or 42.1% of revenues for the six months ended June 30, 2007, and is for an initial term of two years with subsequent extensions by mutual written agreement. Termination of the contract by either party may only be effected by reason of failure to perform that has not been corrected within agreed upon timeframes.

The Company’s contracts with its customers are typically for initial terms of one year with automatic annual extensions, unless either party terminates by giving the requisite notice. Such contracts generally provide for cancellation by either party with 60 to 90 days written notice prior to the expiration of the then current terms.

Note 6 — Preferred Stock

     As of June 30, 2007, there were 4,340 remaining shares of preferred stock authorized and available to issue, and 14,400 outstanding shares of Series A Preferred Stock. All outstanding shares were issued in June 2005 as a result of the sale of Series A Preferred Stock to Woodcliff for approximately $3.4 million in net cash proceeds. The Series A Preferred Stock, acquired by Hythiam in January 2007, is convertible into 4,235,328 shares of common stock at a conversion rate of 294.12 common shares for each preferred share. Hythiam has the right to designate the majority of the board of directors, has dividend and liquidation preferences, and anti-dilution protection. In addition, the Company needs Hythiam’s consent for a sale or merger involving a material portion of its assets or business, any single or series of related transactions exceeding $500,000, and prior to incurring any debt in excess of $200,000.

     The company is authorized to issue shares of Preferred Stock, $50.00 par value, in one or more series, each series to have such designation and number of shares as the Board of Directors may fix prior to the issuance of any shares of such series. Each series may have such preferences and relative participation, optional or special rights with such qualifications, limitations or restrictions stated in the resolution or resolutions providing for the issuance of such series as may be adopted from time to time by the Board of Directors prior to the issuance of any such series.

Note 7— Commitments and Contingencies

(1) The Company provided behavioral healthcare services to the members of a Connecticut HMO from 2001 to 2005 under a contract that provided that the Company would also receive funds directly from a state reinsurance program for the purpose of paying providers. At June 30, 2007, $2.5 million of reinsurance claims payable remains and is attributable to providers having submitted claims for authorized services having incorrect service codes or otherwise incorrect information that has caused payment to be denied by the Company. In such cases, there are contractual and statutory provisions that allow the provider to appeal a denied claim. If no appeal is received by the Company within the prescribed amount of time, the Company may be required to remit the reinsurance funds back to the appropriate party. At June 30, 2007, management believes no further unpaid claims remain, but has not reduced the claims liability since the statutory limits have not expired relating to such claims.

(2) In connection with the Company’s new Indiana contract that started January 1, 2007, the Company is required to maintain a performance bond in the amount of $1,000,000. In addition, a $25,000 performance bond is maintained in relation to a Third Party Administrator license in Maryland.

(3) Related to the Company’s discontinued hospital operations, Medicare guidelines allow the Medicare fiscal intermediary to re-open previously filed cost reports. The Company’s fiscal 1999 cost report, the final year the Company was required to file a cost report is being reviewed, in which case the intermediary may determine that additional amounts are due to or from Medicare. Management believes cost reports for fiscal years prior to fiscal 1999 are closed and considered final.

(4) The Company has insurance for a broad range of risks as it relates to its business operations. The Company maintains managed care errors and omissions, professional and general liability coverage. These policies are written on a claims-made basis and are subject to a $100,000 per claim self-insured retention. The managed care errors and omissions and professional liability policies include limits of liability of $1 million per claim and $3 million in the aggregate. The general liability has a limit of liability of $5 million per claim and $5 million in the aggregate. The Company is responsible for claims within the self-insured retentions or if the policy limits are exceeded. Management is not aware of any claims that could have a material adverse impact on the Company’s consolidated financial statements.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

(5) On January 12, 2007, the members of Woodcliff sold their outstanding membership interests in Woodcliff to Hythiam. Following the change in membership interest of Woodcliff, three existing Company board members formerly nominated by Woodcliff resigned, and the Board of Directors appointed three new board members proposed by Hythiam. The acquisition by Hythiam of the Woodcliff membership interests constitutes a “change of control” pursuant to the terms of the Company’s employment agreement with its Chief Executive Officer (“CEO”), which would entitle the CEO to be paid a severance benefit equal to twenty-four months base salary totaling $410,000 if she elects to terminate, at her sole discretion, her employment at any time within one year following the change in control.

(6) Two class action lawsuits and a complaint have been filed against the Company in the Delaware Court of Chancery. Until the actions are withdrawn or settled, the Company may incur further legal defense fees and may be subject to awards of plaintiff’s attorney fees or other fees, the amounts of which are not presently known or reasonably estimable. See Part I, Item 3, “Legal Proceedings” for a description of these matters.

Note 8 — Related Party Transactions

     In August 2005, the Company’s principal operating subsidiary, Comprehensive Behavioral Care, Inc. (“CBC”), entered into a marketing agreement with Health Alliance Network, Inc. (“HAN”) whereby CBC appointed HAN as its primary representative and marketing agent for commercial business. Two shareholders of HAN held membership interests in Woodcliff, the owner of a controlling interest in the Company. On January 12, 2007, the members of Woodcliff sold 100% of their outstanding membership interests in Woodcliff to Hythiam. For the three and six months ended June 30, 2007, CBC paid HAN $18,000 and $36,000, respectively, and $9,000 and $54,000, for the three and six months ended June 30, 2006, respectively.

     In February 2006, CBC entered into an agreement with Hythiam whereby CBC would have the exclusive right to market Hythiam’s substance abuse disease management program to its current and certain mutually agreed upon prospective clients. The program is an integrated disease management approach designed to offer less restrictive levels of care in order to minimize repeat detoxifications. Under the agreement, CBC will pay Hythiam license and service fees for each enrollee who is treated. David Schuster, then a director, held the position of Vice President of Corporate Development for Hythiam during the period coinciding with the negotiation and initial term of the agreement. Mr. Schuster resigned as a director on June 25, 2007. As of June 30, 2007 there had been no material transactions resulting from this agreement. On January 12, 2007, Hythiam acquired a controlling interest in the Company.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     In addition to historical information, the following information contains forward-looking statements as defined under federal securities laws. Such statements include, but are not limited to, statements concerning the Company’s anticipated operating results, financial resources, increases in revenues, increased profitability, interest expense, growth and expansion, and the ability to obtain new behavioral healthcare contracts. These statements are based on current expectations, estimates and projections about the industry and markets in which Comprehensive Care Corporation (“CompCare” or the “Company”) operates, and management’s beliefs and assumptions. Forward-looking statements are not guarantees of future performance and involve certain known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, but are not limited to, changes in local, regional, and national economic and political conditions, the effect of governmental regulation, competitive market conditions, varying trends in member utilization, our ability to manage healthcare operating expenses, our ability to achieve expected results from new business, the profitability of our capitated contracts, cost of care, seasonality, the Company’s ability to obtain additional financing, and other risks detailed herein and from time to time in the Company’s SEC reports. The following discussion should be read in conjunction with the accompanying consolidated financial statements and notes thereto of CompCare appearing elsewhere herein.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

OVERVIEW

GENERAL

     We are a Delaware corporation organized in 1969. Unless the context otherwise requires, all references to us include our wholly owned operating subsidiary, Comprehensive Behavioral Care, Inc.^{SM (1)} (CBC) and subsidiary corporations.

     Primarily through CBC, we provide managed care services in the behavioral health and psychiatric fields, which is our only operating segment. We coordinate and manage the delivery of a continuum of psychiatric and substance abuse services to:

	•		Commercial members
	•		Medicare members
	•		Medicaid members
	•		Children’s Health Insurance Program (CHIP) members

     on behalf of:

	•		employers
	•		health plans
	•		government organizations
	•		third-party claims administrators
	•		commercial purchasers
	•		other group purchasers of behavioral healthcare services

     Our customer base includes both private and governmental entities. We provide services primarily by a contracted network of providers that includes:

	•		psychiatrists
	•		psychologists
	•		therapists
	•		other licensed healthcare professionals
	•		psychiatric hospitals
	•		general medical facilities with psychiatric beds
	•		residential treatment centers
	•		other treatment facilities

     The services provided through our provider network include outpatient programs (such as counseling or therapy), intermediate care programs (such as intensive outpatient programs and partial hospitalization services), and inpatient and crises intervention services. We do not directly provide treatment or own any provider of treatment services.

     We typically enter into contracts on an annual basis to provide managed behavioral healthcare and substance abuse treatment to our clients’ members. Our arrangements with our clients fall into two broad categories: capitation arrangements, where our clients pay us a fixed fee per member, and fee-for-service and administrative service arrangements where we may manage behavioral healthcare programs or perform various managed care services. We derived 96.9% or $17.3 million of our revenues from capitation arrangements for the six months ended June 30, 2007. Under capitation arrangements, we receive premiums from our clients based on the number of covered members as reported to us by our clients. The amount of premiums we receive for each member is fixed at the beginning of the contract term. These premiums may be subsequently adjusted, up or down, generally at the commencement of each renewal period.

     Our largest expense is the cost of behavioral health services that we provide, which is based primarily on our arrangements with healthcare providers. Since we are subject to increases in healthcare operating expenses based on an increase in the number and frequency of our members seeking behavioral care services, our profitability depends on our ability to predict and effectively manage healthcare operating expenses in relation to the fixed premiums we

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

receive under capitation arrangements. Providing services on a capitation basis exposes us to the risk that our contracts may ultimately be unprofitable if we are unable to anticipate or control healthcare costs. Estimation of healthcare operating expense is our most significant critical accounting estimate. See “Management’s Discussion and Analyses of Financial Condition and Results of Operations — Critical Accounting Estimates.”

RECENT DEVELOPMENTS

     On January 12, 2007, Hythiam, Inc., a healthcare services management company focusing on solutions for those suffering from alcoholism and other substance dependencies, gained a majority, controlling interest in us by purchasing the membership interests of Woodcliff Healthcare Investment Partners, LLC, now a wholly owned subsidiary of Hythiam. Since February 2006, we have had a marketing agreement with Hythiam under which we have the right to offer its PROMETA^® treatment programs as part of a disease management offering to our customers and other mutually agreed parties on an exclusive basis.

     Hythiam owns 1,739,130 shares of our common stock and 14,400 shares of our Series A Convertible Preferred Stock. The Preferred Stock is convertible into 4,235,328 shares of our common stock. Assuming conversion, Hythiam has the ability to control 5,974,458 shares or 50.05% of our common stock based on shares outstanding at August 6, 2007. Hythiam has dividend and liquidation preferences, anti-dilution protection, and the right to appoint a majority of our board of directors. In addition, we are required to obtain Hythiam’s consent for a sale or merger involving a material portion of our assets or business, and prior to entering into any single or series of related transactions exceeding $500,000 or incurring any debt in excess of $200,000. After Hythiam acquired Woodcliff, three of our existing board members resigned and our board appointed three new directors proposed by Hythiam.

     On January 18, 2007, we entered into an Agreement and Plan of Merger (“the Merger Agreement”) with Hythiam, as amended on January 26, 2007, whereby we would merge with a newly formed, wholly-owned subsidiary of Hythiam, with CompCare surviving the merger as a wholly-owned subsidiary of Hythiam. Our board of directors approved the merger subject to approval by a majority interest of our stockholders. To complete the merger, Hythiam would acquire our remaining outstanding shares in exchange for Hythiam common stock. On January 23, 2007 and February 1, 2007, respectively, two stockholder class action lawsuits were filed in Delaware Chancery Court seeking to enjoin the proposed merger. See Part II, Item 1 “Legal Proceedings” for a discussion of these lawsuits.

     On May 21, 2007, our Board of Directors approved a change in our fiscal year end from May 31 to December 31, effective December 31, 2006, to align our fiscal year end with that of Hythiam to obtain reporting efficiencies and cost reductions. In addition, a calendar year end will coincide with that of a new client that is estimated to provide approximately 41% of our annual revenues during the 2007 calendar year. The seven months ended December 31, 2006 is our transition period and our new fiscal year began January 1, 2007 and will end December 31, 2007.

     On May 25, 2007, we mutually agreed to terminate the Merger Agreement, releasing all parties from any and all liabilities and further obligations arising under the agreement. For the foreseeable future we will continue as a majority-owned, controlled subsidiary of Hythiam, which has publicly indicated that it has determined that it can effectuate substantially all of the benefits of its relationship with us under the current operational structure.

     On July 19, 2007, we received from an existing client in Texas a notice of termination, which, if we are not successful in reinstating or obtaining an extension, will result in termination of our contract effective November 30, 2007. This client accounted for 8.6%, or $1.5 million, of our revenues for the six months ended June 30, 2007 and has been a customer since 1998.

     On August 1, 2007, we began providing behavioral healthcare services to approximately 23,000 Medicare members from an existing client in Pennsylvania. Such services are estimated to generate between $4.5 and $5.0 million in annual revenues.

Results of Operations

     For the six months ended June 30, 2007, we reported a net loss of $1.8 million, or $0.24 loss per share (basic and diluted). In comparison, we reported a net loss of $69,000, or $0.01 loss per share (basic and diluted), for the six months ended June 30, 2006.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

     Our marketing efforts to sell the eye care memberships we acquired in November 2004 have not been successful. At May 31, 2006, we recorded a valuation reserve of 50%, or $62,500, to reduce the carrying value of the memberships to our best estimate of recoverable value. Our marketing efforts have continued during calendar 2007 but have yet to result in sales of the memberships. During the quarter ended June 30, 2007, a further valuation reserve was recorded to reduce the remaining carrying value to zero.

     The following tables summarize the Company’s operating results from continuing operations for the three and six months ended June 30, 2007 and 2006 (amounts in thousands):

The Three Months Ended June 30, 2007 Compared to the Three Months Ended June 30, 2006:

		Three Months Ended
		June 30,
		2007				2006
Operating revenues:
Capitated contracts		$	8,848				4,762
Non-capitated sources			311				162
Total operating revenues			9,159				4,924
Operating expenses:
Healthcare operating expenses:
Claims expense(1)			7,550				3,140
Other healthcare operating expenses(1)			1,798				1,021
Total healthcare operating expenses			9,348				4,161
General and administrative expenses			931				790
Bad Debt			2				4
Depreciation and amortization			38				22
Total operating expenses			10,319				4,977
Operating loss		$	(1,160	)			(53	)

(1) Claims expense reflects the cost of revenue of capitated contracts, and other healthcare operating expense reflects the cost of revenue of capitated and non-capitated contracts.

     Operating revenues from capitated contracts increased 85.8%, or approximately $4.1 million, to $8.8 million for the quarter ended June 30, 2007 compared to $4.7 million for the quarter ended June 30, 2006. The increase is primarily attributable to the addition of a new major client in Indiana, which accounted for $3.9 million, and a new client in Michigan, which accounted for approximately $219,000. Additional business from three existing customers in Michigan and Texas also increased revenues by approximately $851,000. This is offset by the loss of one major customer in Texas, which accounted for approximately $879,000 for the three months ending June 30, 2006. Revenue from non-capitated sources increased 92.0% or approximately $149,000, to $311,000 for the quarter ended June 30, 2007, compared to $162,000 for the quarter ended June 30, 2006. The increase is primarily due to additional business in Texas from an existing client.

     Claims expense on capitated contracts increased approximately $4.4 million or 140.4% for the three months ended June 30, 2007 as compared to the three months ended June 30, 2006 due to higher capitated revenues. Claims expense as a percentage of capitated revenues increased from 65.9% for the three months ended June 30, 2006 to 85.3% for the three months ended June 30, 2007 due primarily to increased utilization of covered services by members of our new Indiana contract. Other healthcare expenses, attributable to servicing both capitated contracts and non-capitated contracts, increased 76.1%, or approximately $777,000 due primarily to workforce additions in response to the aforementioned increase in revenues in Indiana.

     General and administrative expenses increased by 17.8%, or approximately $141,000 for the quarter ended June 30, 2007 as compared to the quarter ended June 30, 2006. The increase in general and administrative expense is primarily attributable to recruitment fees paid in conjunction with the hiring of a new Chief Development Officer and fees for the audit of our December 31, 2006 financial statements due to our change in fiscal year. General and administrative expense as a percentage of operating revenue decreased from 16.0% for the quarter ended June 30, 2006 to 10.2% for the quarter ended June 30, 2007, due to higher operating revenues.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

The Six Months Ended June 30, 2007 Compared to the Six Months Ended June 30, 2006:

		Six Months Ended
		June 30,
		2007				2006
Operating revenues:
Capitated contracts		$	17,315			$	9,714
Non-capitated sources			545				319
Total operating revenues			17,860				10,033
Operating expenses:
Healthcare operating expenses:
Claims expense(1)			14,464				6,305
Other healthcare operating expenses(1)			3,147				2,003
Total healthcare operating expense			17,611				8,308
General and administrative expenses			2,012				1,585
Recovery of doubtful accounts			(8	)			(52	)
Depreciation and amortization			76				43
Total operating expenses			19,691				9,884
Operating (loss) income		$	(1,831	)		$	149

(1) Claims expense reflects the cost of revenue of capitated contracts, and other healthcare operating expense reflects the cost of revenue of capitated and non-capitated contracts.

     Capitated contract revenues increased 78.2%, or approximately $7.6 million, to approximately $17.3 million for the six months ended June 30, 2007 compared to $9.7 million for the six months ended June 30, 2006. The increase is primarily attributable to the addition of a new major client in Indiana, which accounted for $7.5 million, and a new client in Michigan, which accounted for approximately $438,000. Additional business from four existing customers in Michigan, Maryland and Texas also increased revenues by approximately $2.1 million. This is offset by the loss of one major customer in Texas, which accounted for approximately $2.2 million for the six months ending June 30, 2006. Non-capitated revenue increased 70.8%, or approximately $226,000, to approximately $545,000 for the six months ended June 30, 2007, compared to approximately $319,000 for the six months ended June 30, 2006. The increase is primarily due to additional business in Texas from an existing client.

     Claims expense on capitated contracts increased approximately $8.2 million or 129.4% for the six months ended June 30, 2007 as compared to the six months ended June 30, 2006 due to higher capitated revenues. Claims expense as a percentage of capitated revenues increased from 64.9% for the six months ended June 30, 2006 to 83.5% for the six months ended June 30, 2007 due primarily to increased utilization of covered services by members of our new Indiana contract. Other healthcare expenses, which are incurred to service both capitated and non-capitated contracts, increased approximately $1.1 million, or 57.1%, due primarily to workforce additions in response to the aforementioned increase in revenues in Indiana.

     General and administrative expenses increased by $427,000, or 26.9%, for the six months ended June 30, 2007 as compared to the six months ended June 30, 2006. The increase in general and administrative expense is primarily attributable to the expensing of prepaid fees paid to former directors following their resignation. Additionally, $135,000 of legal fee expense was incurred related to the proposed merger with Hythiam and with two class action lawsuits brought by two minority shareholders. General and administrative expense as a percentage of operating revenue decreased from 15.8% for the six months ended June 30, 2006 to 11.3% for the six months ended June 30, 2007.

Seasonality of Business

     Historically, we have experienced increased member utilization during the months of March, April and May, and consistently low utilization by members during the months of June, July, and August. Such variations in member utilization impact our costs of care during these months, generally having a positive impact on our gross margins and operating profits during the June through August period and a negative impact on our gross margins and operating profits during the months of March through May. Corresponding with historical patterns, we experienced higher utilization costs during the period March 2007 through May 2007. Utilization costs exceeding expectations and not

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

attributable to seasonality are addressed through a rate increase request to the applicable client. We may continue to experience increased utilization costs in subsequent periods.

Concentration of Risk

     For the six months ended June 30, 2007, 86.2% of our operating revenue was concentrated in contracts with six health plans to provide behavioral healthcare services under commercial, Medicare, Medicaid, and CHIP plans. For the same period of the prior year, 86.4% of our operating revenue was concentrated in contracts with seven health plans. The term of each contract is generally for one year and is automatically renewable for additional one-year periods unless terminated by either party by giving the requisite written notice. The loss of one or more of these clients, unless replaced by new business, would negatively affect the financial condition of the Company.

Liquidity and Capital Resources

     During the six months ended June 30, 2007, our cash and cash equivalents increased by $1.7 million, primarily due to timing differences of monies received from our new Indiana contract that started January 1, 2007 and claims received for payment from our providers related to this contract. Cash flows attributed to investing activities consist primarily of $46,000 in outflows for additions to property and equipment offset by $30,000 in cash provided by proceeds from available-for-sale securities.

     For the six months ended June 30, 2006, our cash and cash equivalents decreased by $1.2 million due primarily to payment of claims following the end of a major Connecticut contract on December 31, 2005 and the termination of a major Texas contract on May 31, 2006. Cash used in investing activities amounted to $28,000 for additions to property and equipment.

     At June 30, 2007, cash and cash equivalents were approximately $7.2 million. Although we had a working capital deficit of $1.7 million and a stockholders’ deficit of $2.6 million at June 30, 2007, we expect positive net cash flow from new contracts that started January 1, 2007 and as a result, management believes we will have positive cash flow during 2007 and sufficient cash reserves to sustain current operations and to meet our current obligations.

     Our unpaid claims liability is estimated using an actuarial paid completion factor methodology and other statistical analyses. These estimates are subject to the effects of trends in utilization and other factors. Any significant increase in member utilization that falls outside of our estimations would increase healthcare operating expenses and may impact our ability to achieve and sustain profitability and positive cash flow. Although considerable variability is inherent in such estimates, we believe that our unpaid claims liability is adequate. However, actual results could differ from the $5.2 million claims payable amount reported as of June 30, 2007.

Critical Accounting Estimates

     Our discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires us to make significant estimates and judgments to develop the amounts reflected and disclosed in the consolidated financial statements, most notably our estimate for claims incurred but not yet reported (“IBNR”). On an on-going basis, we evaluate the appropriateness of our estimates and we maintain a thorough process to review the application of our accounting policies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

     We believe our accounting policies specific to revenue recognition, accrued claims payable, premium deficiencies, goodwill, and stock compensation expense involve our most significant judgments and estimates that are material to our consolidated financial statements (see Note 1 — “Description of the Company’s Business and Basis Presentation” to the unaudited, consolidated financial statements).

Revenue Recognition

     We provide managed behavioral healthcare and substance abuse services to recipients, primarily through subcontracts with HMOs. Revenue under the vast majority of these agreements is earned and recognized monthly based on the number of covered members as reported to us by our clients regardless of whether services actually provided are lesser or greater than anticipated when we entered into such contracts (generally referred to as capitation

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

arrangements). The information regarding the number of covered members is supplied by our clients and we review membership eligibility records and other reported information to verify its accuracy in calculating the amount of revenue to be recognized. Consequently, the vast majority of our revenue is determined by the monthly receipt of covered member information and the associated payment from the client, thereby removing uncertainty and precluding us from needing to make assumptions to estimate monthly revenue amounts.

     We may experience adjustments to our revenues to reflect changes in the number and eligibility status of members subsequent to when revenue is recognized. Subsequent adjustments to our revenue have not been material.

Accrued Claims Payable and Claims Expense

     Healthcare operating expenses are composed of claims expense and other healthcare expenses. Claims expense includes amounts paid to hospitals, physician groups and other managed care organizations under capitated contracts. Other healthcare expenses include items such as information systems, case management and quality assurance, attributable to both capitated and non-capitated contracts.

     The cost of behavioral health services is recognized in the period in which an eligible member actually receives services and includes an estimate of IBNR (as defined below). We contract with various healthcare providers including hospitals, physician groups and other managed care organizations either on a discounted fee-for-service or a per-case basis. We determine that a member has received services when we receive a claim within the contracted timeframe with all required billing elements correctly completed by the service provider. We then determine whether (1) the member is eligible to receive such services, (2) the service provided is medically necessary and is covered by the benefit plan’s certificate of coverage, and (3) the service has been authorized by one of our employees. If all of these requirements are met, the claim is entered into our claims system for payment and the associated cost of behavioral health services is recognized.

     Accrued claims payable consists primarily of reserves established for reported claims and claims incurred but not yet reported (“IBNR”), which are unpaid through the respective balance sheet dates. Our policy is to record management’s best estimate of IBNR. The IBNR liability is estimated monthly using an actuarial paid completion factor methodology and is continually reviewed and adjusted, if necessary, to reflect any change in the estimated liability as more information becomes available. In deriving an initial range of estimates, we use an actuarial model that incorporates past claims payment experience, enrollment data and key assumptions such as trends in healthcare costs and seasonality. Authorization data, utilization statistics, calculated completion percentages and qualitative factors are then combined with the initial range to form the basis of management’s best estimate of the accrued claims payable balance.

     At June 30, 2007, the initial range of accrued claims payable was between $4.9 million and $5.3 million. Based on the information available, we determined our best estimate of the accrued claims liability to be $5.2 million. Approximately $2.2 million of the $5.2 million accrued claims payable balance at June 30, 2007 is attributable to our new major contract in Indiana that started January 1, 2007. As of June 30, 2007 we have accrued as claims expense approximately 97.6% of the revenue from this contract. Of this amount, seventy percent has been paid and thirty percent is included in our accrued claims payable balance at June 30, 2007. Due to limited historical claims payment data, we have estimated the IBNR for this contract primarily by using estimated completion factors based on authorization data.

     At December 31, 2006, the initial accrued claims payable range was between $2.6 and $2.9 million, and our best estimate was determined to be $2.7 million. We have used the same methodology and assumptions for estimating the IBNR portion of the accrued claims liability for each fiscal quarter-end.

     Accrued claims payable at June 30, 2007 and December 31, 2006 comprises approximately $1.1 million and, $0.7 million, respectively, of submitted and approved claims, which had not yet been paid, and $4.1 million and, $2.0 million for IBNR claims, respectively.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

     Many aspects of our business are not predictable with consistency, and therefore, estimating IBNR claims involves a significant amount of management judgment. Actual claims incurred could differ from the estimated claims payable amount presented. The following are factors that would have an impact on our future operations and financial condition:

	•		Changes in utilization patterns
	•		Changes in healthcare costs
	•		Changes in claims submission timeframes by providers
	•		Success in renegotiating contracts with healthcare providers
	•		Occurrence of catastrophes
	•		Changes in benefit plan design
	•		The impact of present or future state and federal regulations

     A 5% increase in assumed healthcare cost trends from those used in our calculations of IBNR at June 30, 2007, could increase our claims expense by approximately $84,000 and reduce our net results per share by $0.01 per share as illustrated in the table below:

Change in Healthcare Costs:
		(Decrease)
(Decrease)		Increase
Increase		In Claims Expense
(5%)		($86,000)
5%		$84,000

Premium Deficiencies

     We accrue losses under our capitated contracts when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. We perform this loss accrual analysis on a specific contract basis taking into consideration such factors as future contractual revenue, projected future healthcare and maintenance costs, and each contract’s specific terms related to future revenue increases as compared to expected increases in healthcare costs. The projected future healthcare and maintenance costs are estimated based on historical trends and our estimate of future cost increases.

     At any time prior to the end of a contract or contract renewal, if a capitated contract is not meeting its financial goals, we generally have the ability to cancel the contract with 60 to 90 days’ written notice. Prior to cancellation, we will usually submit a request for a rate increase accompanied by supporting utilization data. Although our clients have historically been generally receptive to such requests, no assurance can be given that such requests will be fulfilled in the future in the our favor. If a rate increase is not granted, we have the ability to terminate the contract and limit our risk to a short-term period.

     On a quarterly basis, we perform a review of our portfolio of contracts for the purpose of identifying loss contracts (as defined in the American Institute of Certified Public Accountants Audit and Accounting Guide — Health Care Organizations) and developing a contract loss reserve, if applicable, for succeeding periods. During the three months ended June 30, 2007, we did not identify any contracts where it was probable that a loss had been incurred and for which a loss could reasonably be estimated.

Goodwill

     We evaluate at least annually the amount of our recorded goodwill by performing an impairment test that compares the carrying amount to an estimated fair value. In estimating the fair value, management makes its best assumptions regarding future cash flows and a discount rate to be applied to the cash flows to yield a present, fair value of equity. As a result of such tests, management believes there is no material risk of loss from impairment of goodwill. However, actual results may differ significantly from management’s assumptions, resulting in potentially adverse impact to our consolidated financial statements.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Stock Compensation Expense

     We issue stock-based awards to our employees and members of our Board of Directors. Effective June 1, 2006, we adopted SFAS 123R and elected to apply the modified-prospective method to measure compensation cost for stock options at fair value on the grant date and recognize compensation cost on a straight-line basis over the service period for those options expected to vest. We use the Black-Scholes option pricing model, which requires certain variables for input to calculate the fair value of a stock award on the grant date. These variables include the expected volatility of our stock price, award exercise behaviors, the risk free interest rate, and expected dividends. We use significant judgment in estimating expected volatility of the stock, exercise behavior and forfeiture rates.

Expected Volatility
We estimate the volatility of the share price by using historical data of our traded stock in combination with management’s expectation of the extent of fluctuation in future stock prices. We believe our historical volatility is more representative of future stock price volatility and as such it has been given greater weight in estimating future volatility.

Expected Term
A variety of factors are considered in determining the expected term of options granted. Options granted are grouped by their homogeneity, based on the optionees’ position, whether managerial or clerical, and length of service and turnover rate. Where possible, we analyze exercise and post-vesting termination behavior. For any group without sufficient information, we estimate the expected term of the options granted by averaging the vesting term and the contractual term of the options.

Expected Forfeiture Rate
We generally separate our option awards into two groups: employee and non-employee awards. The historical data of each group are analyzed independently to estimate the forfeiture rate of options at the time of grant. These estimates are revised in subsequent periods if actual forfeitures differ from estimated forfeitures.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

     While we currently have market risk sensitive instruments, we have no significant exposure to changing interest rates as the interest rate on our long-term debt is fixed. Additionally, we do not use derivative financial instruments for investment or trading purposes and our investments are generally limited to cash deposits.

Item 4. Controls and Procedures

     Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report, and, based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective. There have been no changes in our internal controls over financial reporting identified in connection with this evaluation that occurred during the period covered by this report and that have affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

     We and nine current and former board members were named as defendants in two class action lawsuits filed by two shareholders on January 23, 2007 and February 1, 2007, respectively. In the similar complaints, filed in the Chancery Court of Delaware, the plaintiffs seek permanent injunctive and other equitable relief to prevent Hythiam from acquiring 49.95% of our outstanding common shares that it does not currently own (either directly or through its wholly owned subsidiary, Woodcliff) from the remaining minority shareholders. The plaintiffs allege that the consideration being proposed to the minority shareholders by Hythiam is inadequate, through coercive means, without fair process and through material misleading information.

     On May 25, 2007, we mutually terminated the Agreement and Plan of Merger. The plaintiffs’ counsel has acknowledged that the lawsuits are now moot and has agreed to dismiss them, but has not yet done so.

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

     On June 15, 2007, a complaint was filed against us by two stockholders in the Delaware Court of Chancery. The complaint seeks an order compelling us to deliver copies of requested books and records pursuant to Section 220 of the Delaware General Corporation Law. In addition, the complaint seeks payment of reasonable fees and expenses to the plaintiffs and such other further relief that the Court may deem just and proper. We filed an answer to the complaint on July 11, 2007, in which we contend that the demand made by the plaintiffs does not comply with the form and manner of making a demand for inspection under Section 220 that the plaintiffs failed to set forth or establish a proper purpose for inspection, and that the documents the plaintiffs seek to inspect are overly broad. We have offered to produce appropriate documents pursuant to a reasonable protective order, to which the plaintiffs have refused to agree.

     From time to time, we may be party to, and our property may be subject to, ordinary, routine litigation incidental to our business. Claims may exceed insurance policy limits and we may have exposure to a liability that is not covered by insurance. We are not aware of any such lawsuits that could have a material adverse impact on our consolidated financial statements.

Item 1A. Risk Factors

     The Risk Factors included in our Transition Report on Form 10-K for the seven months ended December 31, 2006 have not materially changed.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

     Not Applicable.

Item 3. Defaults Upon Senior Securities

     Not applicable.

Item 4. Submission of Matters to a Vote of Security Holders

     Not applicable.

Item 5. Other Information

     Not applicable.

Item 6. Exhibits

EXHIBIT
NUMBER				DESCRIPTION
	31.1			Comprehensive Care Corporation CEO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	31.2			Comprehensive Care Corporation CFO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	32.1			Comprehensive Care Corporation CEO Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
	32.2			Comprehensive Care Corporation CFO Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		COMPREHENSIVE CARE CORPORATION
August 9, 2007
		By		/s/ MARY JANE JOHNSON
				Mary Jane Johnson President and Chief Executive Officer (Principal Executive Officer)
		By		/s/ ROBERT J. LANDIS
				Robert J. Landis Chairman, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)